Open AccessTreatment of hypertension depending on the effect of beta-adrenoblockers on blood serum lipids and lipoproteins
Author(s) -
В. П. Тихонов,
Ė. U. Umurzakov,
М. Е. Стаценко,
F. A. Nemchuk
Publication year - 1989
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99766
Subject(s) - propranolol , blood lipids , medicine , endocrinology , beta (programming language) , cholesterol , adverse effect , adrenergic receptor , pharmacology , receptor , computer science , programming language
Beta-adrenergic receptor blockers are widely used in the treatment of hypertension. However, in recent years, there have been reports of their adverse effects on lipid metabolism - an increase in triglycerides, to a lesser extent in cholesterol and low-density lipoproteins, a decrease in high-density lipoproteins. At the same time, a number of authors did not note such results. Discrepancy in the data is primarily due to the heterogeneity of hypertensive patients, although analysis of the literature suggests that in some hypertensive patients the level of lipids and atherogenic lipoproteins may increase with prolonged treatment with propranolol.